Page last updated: 2024-11-02

oxybutynin and Dermal Sinus

oxybutynin has been researched along with Dermal Sinus in 2 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research Excerpts

ExcerptRelevanceReference
"The patients who had lower urinary tract symptoms (LUTS) were classified as nonmonosymptomatic NE (NMNE)."2.87The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial. ( Bayar, G; Kilinc, MF; Sariogullari, U; Yavuz, A, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yavuz, A1
Bayar, G1
Kilinc, MF1
Sariogullari, U1
Hehir, M1
Fitzpatrick, JM1

Trials

1 trial available for oxybutynin and Dermal Sinus

ArticleYear
The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial.
    Urology, 2018, Volume: 120

    Topics: Antidiuretic Agents; Child; Deamino Arginine Vasopressin; Female; Humans; Lower Urinary Tract Sympto

2018

Other Studies

1 other study available for oxybutynin and Dermal Sinus

ArticleYear
Oxybutinin and the prevention of urinary incontinence in spina bifida.
    European urology, 1985, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Child; Female; Humans; Male; Mandelic Acids; Parasympatholytics; Prospective Stud

1985